These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 30830285)
1. Use of systemic glucocorticoids in patients with psoriatic arthritis by Argentinian and other Latin-American rheumatologists. Aimo C; Cosentino VL; Sequeira G; Kerzberg E Rheumatol Int; 2019 Apr; 39(4):723-727. PubMed ID: 30830285 [TBL] [Abstract][Full Text] [Related]
2. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey. van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420 [TBL] [Abstract][Full Text] [Related]
3. An eight-year multicenter study on short-term peripheral intravenous catheter-related bloodstream infection rates in 100 intensive care units of 9 countries in Latin America: Argentina, Brazil, Colombia, Costa Rica, Dominican Republic, Ecuador, Mexico, Panama, and Venezuela. Findings of the International Nosocomial Infection Control Consortium (INICC). Rosenthal VD; Chaparro GJ; Servolo-Medeiros EA; Souza-Fram D; Escudero DVDS; Gualtero-Trujillo SM; Morfin-Otero R; Gonzalez-Diaz E; Rodriguez-Noriega E; Altuzar-Figueroa MA; Aguirre-Avalos G; Mijangos-Méndez JC; Corona-Jiménez F; Hernandez-Chena BE; Abu-Jarad MR; Diaz-Hernandez EM; Miranda-Novales MG; Vázquez-Rosales JG; Aguilar-De-Morós D; Castaño-Guerra E; Munoz-Gutierrez G; Mejia N; Acebo-Arcentales JJ; Di-Silvestre G Infect Control Hosp Epidemiol; 2021 Sep; 42(9):1098-1104. PubMed ID: 33441207 [TBL] [Abstract][Full Text] [Related]
4. Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study. Mease PJ; Liu C; Siegel E; Richmond H; Wu M; Chen L; Douglas K; Lockshin B Am J Clin Dermatol; 2019 Dec; 20(6):873-880. PubMed ID: 31612380 [TBL] [Abstract][Full Text] [Related]
5. A national survey on the management of psoriatic arthritis using the Delphi method. Lubrano E; Cantini F; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Marchesoni A Clin Exp Rheumatol; 2017; 35(2):214-220. PubMed ID: 27607572 [TBL] [Abstract][Full Text] [Related]
6. Singapore Chapter of Rheumatologists consensus statement on the eligibility for government subsidy of biologic disease modifying anti-rheumatic agents for the treatment of psoriatic arthritis. Lahiri M; Teng GG; Cheung PP; Suresh E; Chia FL; Lui NL; Koh DR; Koh WH; Leong KP; Lim AYN; Ng SC; Thumboo J; Lau TC; Leong KH Int J Rheum Dis; 2017 Oct; 20(10):1527-1540. PubMed ID: 26353916 [TBL] [Abstract][Full Text] [Related]
7. Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe. Gottlieb A; Gratacos J; Dikranian A; van Tubergen A; Fallon L; Emir B; Aikman L; Smith T; Chen L Rheumatol Int; 2019 Jan; 39(1):121-130. PubMed ID: 30426237 [TBL] [Abstract][Full Text] [Related]
8. Global partnering opportunities and challenges of psoriasis and psoriatic arthritis in Latin America: a report from the GRAPPA 2010 annual meeting. Espinoza LR; Toloza SM; Valle-Onate R; Mease PJ J Rheumatol; 2012 Feb; 39(2):445-7. PubMed ID: 22298278 [TBL] [Abstract][Full Text] [Related]
9. Current approach to the management of psoriatic arthritis according to a sample of Italian rheumatologists. Marchesoni A; Lubrano E; Manara M; Ramonda R; Salvarani C; Olivieri I Clin Exp Rheumatol; 2016; 34(6):1051-1058. PubMed ID: 27462870 [TBL] [Abstract][Full Text] [Related]
10. The current status and unmet needs in the management of psoriatic arthritis: Viewpoint from physicians in Taiwan. Li TH; Liao HT; Huang YF; Shen YC; Chiu YC; Chen WS; Chen MH; Tsai CY; Chang DM J Formos Med Assoc; 2018 May; 117(5):404-412. PubMed ID: 28552625 [TBL] [Abstract][Full Text] [Related]
11. A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritis. Meyfroidt S; Hulscher M; De Cock D; Van der Elst K; Joly J; Westhovens R; Verschueren P Clin Rheumatol; 2015 May; 34(5):861-9. PubMed ID: 25711874 [TBL] [Abstract][Full Text] [Related]
12. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948 [TBL] [Abstract][Full Text] [Related]
13. Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry. Mease PJ; Lesperance T; Liu M; Collier DH; Mason M; Deveikis S; Accortt NA J Rheumatol; 2017 Feb; 44(2):184-192. PubMed ID: 28089969 [TBL] [Abstract][Full Text] [Related]
14. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America. Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A; Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606 [TBL] [Abstract][Full Text] [Related]
15. Challenges in the Management of Psoriatic Arthritis in Latin America: A Systematic Review. Ribeiro AL; Dullius L; Sartori NS; Azeredo-da-Silva A; Kohem CL; Coates L; Monticielo OA; Palominos P Clin Ther; 2023 Sep; 45(9):860-867. PubMed ID: 37198042 [TBL] [Abstract][Full Text] [Related]
16. Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis. Atzeni F; Costa L; Caso F; Scarpa R; Sarzi-Puttini P J Rheumatol Suppl; 2015 Nov; 93():79-81. PubMed ID: 26523064 [TBL] [Abstract][Full Text] [Related]
17. Psoriatic arthritis: performance of rheumatologists in daily practice. Gorter S; van der Heijde DM; van der Linden S; Houben H; Rethans JJ; Scherpbier AJ; van der Vleuten CP Ann Rheum Dis; 2002 Mar; 61(3):219-24. PubMed ID: 11830426 [TBL] [Abstract][Full Text] [Related]
18. Treatment recommendations for psoriatic arthritis. Ritchlin CT; Kavanaugh A; Gladman DD; Mease PJ; Helliwell P; Boehncke WH; de Vlam K; Fiorentino D; Fitzgerald O; Gottlieb AB; McHugh NJ; Nash P; Qureshi AA; Soriano ER; Taylor WJ; Ann Rheum Dis; 2009 Sep; 68(9):1387-94. PubMed ID: 18952643 [TBL] [Abstract][Full Text] [Related]
19. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings. Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593 [TBL] [Abstract][Full Text] [Related]
20. Oral treatment options for AS and PsA: DMARDs and small-molecule inhibitors. Chan J; Gladman D Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):415-426. PubMed ID: 31171312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]